Company profile DSGN
After 39 days of this quarter the interest is at 38.0. Based on that we can calculate that during remaining 52 days it will total up to 89.0. Design Therapeutics expected interest is significantly lower compared to previous quarter (-47.6%) and same quarter last year (-60.1%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 60 | 95 58.3% QoQ | 106 11.6% QoQ | 94 -11.3% QoQ |
| 2020 | 166 176.7% YoY 76.6% QoQ | 99 4.2% YoY -40.4% QoQ | 90 -15.1% YoY -9.1% QoQ | 149 58.5% YoY 65.6% QoQ |
| 2021 | 285 71.7% YoY 91.3% QoQ | 171 72.7% YoY -40.0% QoQ | 166 84.4% YoY -2.9% QoQ | 150 0.7% YoY -9.6% QoQ |
| 2022 | 246 -13.7% YoY 64.0% QoQ | 202 18.1% YoY -17.9% QoQ | 217 30.7% YoY 7.4% QoQ | 216 44.0% YoY -0.5% QoQ |
| 2023 | 223 -9.3% YoY 3.2% QoQ | 258 27.7% YoY 15.7% QoQ | 268 23.5% YoY 3.9% QoQ | 170 -21.3% YoY -36.6% QoQ |
| 2024 | 38 -83.0% YoY -77.6% QoQ | - | - | - |
The average 5 years interest of Design Therapeutics was 13.29 per week. The last year interest of Design Therapeutics compared to the last 5 years has changed by 22.12%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 106.75%.
There is not enough data for Design Therapeutics genetic diseases to provide analysis
There is not enough data for Design Therapeutics genetic diseases to provide correlation calculation
There is not enough data for Design Therapeutics genetic diseases to provide analysis
There is not enough data for Friedreich Ataxia treatment to provide analysis
There is not enough data for Friedreich Ataxia treatment to provide correlation calculation
There is not enough data for Friedreich Ataxia treatment to provide analysis
There is not enough data for Myotonic Dystrophy Type-1 treatment to provide analysis
There is not enough data for Myotonic Dystrophy Type-1 treatment to provide correlation calculation
There is not enough data for Myotonic Dystrophy Type-1 treatment to provide analysis
After 39 days of this quarter the interest is at 84.0. Based on that we can calculate that during remaining 52 days it will total up to 196.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 173 | 361 108.7% QoQ | 236 -34.6% QoQ | 231 -2.1% QoQ |
| 2020 | 389 124.9% YoY 68.4% QoQ | 300 -16.9% YoY -22.9% QoQ | 191 -19.1% YoY -36.3% QoQ | 190 -17.7% YoY -0.5% QoQ |
| 2021 | 25 -93.6% YoY -86.8% QoQ | 119 -60.3% YoY 376.0% QoQ | 227 18.8% YoY 90.8% QoQ | 37 -80.5% YoY -83.7% QoQ |
| 2022 | 297 1088.0% YoY 702.7% QoQ | 344 189.1% YoY 15.8% QoQ | 167 -26.4% YoY -51.5% QoQ | 112 202.7% YoY -32.9% QoQ |
| 2023 | 170 -42.8% YoY 51.8% QoQ | 263 -23.5% YoY 54.7% QoQ | 134 -19.8% YoY -49.0% QoQ | 145 29.5% YoY 8.2% QoQ |
| 2024 | 84 -50.6% YoY -42.1% QoQ | - | - | - |
The average 5 years interest of Fragile X syndrome treatment was 16.07 per week. The last year interest of Fragile X syndrome treatment compared to the last 5 years has changed by -19.85%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -47.64%.
There is not enough data for Spinocerebellar ataxias treatment to provide analysis
There is not enough data for Spinocerebellar ataxias treatment to provide correlation calculation
There is not enough data for Spinocerebellar ataxias treatment to provide analysis
After 39 days of this quarter the interest is at 90.0. Based on that we can calculate that during remaining 52 days it will total up to 210.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 234 | 58 -75.2% QoQ | 54 -6.9% QoQ | 230 325.9% QoQ |
| 2020 | 150 -35.9% YoY -34.8% QoQ | 112 93.1% YoY -25.3% QoQ | 75 38.9% YoY -33.0% QoQ | 60 -73.9% YoY -20.0% QoQ |
| 2021 | 71 -52.7% YoY 18.3% QoQ | 353 215.2% YoY 397.2% QoQ | 25 -66.7% YoY -92.9% QoQ | 159 165.0% YoY 536.0% QoQ |
| 2022 | 204 187.3% YoY 28.3% QoQ | 102 -71.1% YoY -50.0% QoQ | 123 392.0% YoY 20.6% QoQ | 116 -27.0% YoY -5.7% QoQ |
| 2023 | 247 21.1% YoY 112.9% QoQ | 301 195.1% YoY 21.9% QoQ | 110 -10.6% YoY -63.5% QoQ | 154 32.8% YoY 40.0% QoQ |
| 2024 | 90 -63.6% YoY -41.6% QoQ | - | - | - |
The average 5 years interest of Huntington's disease treatment was 11.6 per week. The last year interest of Huntington's disease treatment compared to the last 5 years has changed by 32.59%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 38.81%.
There is not enough data for Design Therapeutics careers to provide analysis
There is not enough data for Design Therapeutics careers to provide correlation calculation
There is not enough data for Design Therapeutics careers to provide analysis
There is not enough data for Design Therapeutics reviews to provide analysis
There is not enough data for Design Therapeutics reviews to provide correlation calculation
There is not enough data for Design Therapeutics reviews to provide analysis
There is not enough data for Design Therapeutics California to provide analysis
There is not enough data for Design Therapeutics California to provide correlation calculation
There is not enough data for Design Therapeutics California to provide analysis
After 39 days of this quarter the interest is at 42.0. Based on that we can calculate that during remaining 52 days it will total up to 98.0. Design Therapeutics -stock -company expected interest is significantly lower compared to previous quarter (-66.6%) and same quarter last year (-69.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 141 | 99 -29.8% QoQ | 61 -38.4% QoQ | 183 200.0% QoQ |
| 2020 | 71 -49.6% YoY -61.2% QoQ | 93 -6.1% YoY 31.0% QoQ | 169 177.0% YoY 81.7% QoQ | 134 -26.8% YoY -20.7% QoQ |
| 2021 | 250 252.1% YoY 86.6% QoQ | 138 48.4% YoY -44.8% QoQ | 294 74.0% YoY 113.0% QoQ | 246 83.6% YoY -16.3% QoQ |
| 2022 | 245 -2.0% YoY -0.4% QoQ | 214 55.1% YoY -12.7% QoQ | 309 5.1% YoY 44.4% QoQ | 332 35.0% YoY 7.4% QoQ |
| 2023 | 316 29.0% YoY -4.8% QoQ | 343 60.3% YoY 8.5% QoQ | 321 3.9% YoY -6.4% QoQ | 293 -11.7% YoY -8.7% QoQ |
| 2024 | 42 -86.7% YoY -85.7% QoQ | - | - | - |
The average 5 years interest of Design Therapeutics -stock -company was 16.45 per week. The last year interest of Design Therapeutics -stock -company compared to the last 5 years has changed by 33.86%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 117.37%.